Will vitamin E be the hope of patients with NASH and advanced fibrosis? - the reliability is worth discussing.
Sign Up to like & getrecommendations! Published in 2019 at "Hepatology"
DOI: 10.1002/hep.30603
Abstract: According to the article conducted by Eduardo et al.(1), the non-transplant survival rate of nonalcoholic steatohepatitis (NASH) patients with bridging necrosis and cirrhosis, which is a subtype of non-alcoholic fatty liver disease (NAFLD), was found to… read more here.
Keywords: patients nash; nash advanced; hope patients; vitamin hope ... See more keywords
Pirtobrutinib: A New Hope for patients with BTK-inhibitor refractory lymphoproliferative disorders.
Sign Up to like & getrecommendations! Published in 2023 at "Blood"
DOI: 10.1182/blood.2023020240
Abstract: Patients with lymphoproliferative disorders such as CLL and Mantle Cell Lymphoma (MCL) who are resistant to covalent BTK inhibitors (cBTKi), especially if also venetoclax-refractory, have an unmet therapeutic need. Pirtobrutinib, a non-covalent BTK inhibitor, achieves… read more here.
Keywords: pirtobrutinib new; btk inhibitor; refractory; lymphoproliferative disorders ... See more keywords
Surprising Anticancer Activities of Psychiatric Medications: Old Drugs Offer New Hope for Patients With Brain Cancer
Sign Up to like & getrecommendations! Published in 2019 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2019.01262
Abstract: Despite decades of research and major efforts, malignant brain tumors remain among the deadliest of all cancers. Recently, an increasing number of psychiatric drugs has been proven to possess suppressing activities against brain tumors, and… read more here.
Keywords: brain cancer; patients brain; new hope; hope patients ... See more keywords